At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories. That it depends thereby less on large names, but on the future potential and whether the market also recognizes these perspectives, was one of its first learnings at the stock exchange.
On these pages, Nico examines current events at listed companies and takes a closer look at companies that are traded under the radar of the market, in addition to well-known securities.
In order to be able to take advantage of speculative opportunities on the stock exchange, Nico not only focuses on a balanced asset allocation of defensive and opportunity-oriented securities, but also on an intact risk management. "In addition to position size and entry in several tranches, investors should also develop a sense of timing and get to know a stock better before investing," says the columnist.
Commented by Nico Popp
Commented by Nico Popp on October 23rd, 2025 | 07:10 CEST
This raw materials latecomer scores with quality: Power Metallic Mines, Albemarle, Ford
Stagnation looms! After the Dutch government replaced the Chinese CEO at chip manufacturer Nexperia, chip deliveries from China to the EU have come to a halt - production stoppages are now a real threat. The supply of critical raw materials is also anything but secure today. China is tightening the reins not only on semiconductors and rare earths. Beyond strict export controls or outright bans, industry insiders report that a multitude of bureaucratic hurdles are making day-to-day operations increasingly difficult. We take a look at how Western mining and industrial companies are adapting to this new environment and explain why Power Metallic Mines has recently moved into the spotlight for many investors.
Read
Commented by Nico Popp on October 22nd, 2025 | 07:20 CEST
Dividend stocks with that certain something: RE Royalties, freenet, Porsche
Recent media reports of an impending banking crisis in the US have increased market volatility. US President Trump's erratic policies are not exactly helping to calm the markets either. In times like these, some investors are looking for safe havens for their portfolios. For many investors, dividend stocks are the primary choice for this purpose, alongside bonds. We highlight some interesting picks, including RE Royalties, which stands out with a business model that scores points with its unique selling points.
Read
Commented by Nico Popp on October 22nd, 2025 | 07:10 CEST
Hype and day-to-day business – What matters now: European Lithium, BMW, Mercedes-Benz
European Lithium shares have recently caused quite a stir. But what is behind the surge that has multiplied its value within just a few days? What role does the Company actually play - for the US and also for Europe? We sort through the many reports on European Lithium and show where the Company could be headed in the medium term. One thing seems certain: Without European Lithium, the outlook for the automotive industry on both sides of the Atlantic looks bleak. Reason enough to take a closer look at the background.
Read
Commented by Nico Popp on October 22nd, 2025 | 07:00 CEST
Important piece of the puzzle in the fight against cancer: Vidac Pharma, Roche, Merck & Co.
The pharmaceutical market is enormous - and continues to grow. Market research institute Evaluate forecasts an increase to around USD 1.7 trillion by 2030, representing an annual growth rate of 7.7%. Oncology promises the highest sales, at around USD 300 billion. However, there is no single approach. Instead, new modalities and technologies such as antibody-drug conjugates (ADCs), cell and gene therapies, and radiopharmaceuticals are transforming the industry and gaining significant traction. One thing is clear: progress in the biotech sector is increasingly achieved through the combination of active ingredients and technologies. What role does the biotech company Vidac Pharma play in this?
Read
Commented by Nico Popp on October 21st, 2025 | 07:10 CEST
Biotech investors should know these suppliers: Thermo Fisher Scientific, BioNxt, AptarGroup
While new drugs dominate the headlines, it is often suppliers and service providers that deliver solid long-term returns. Three examples: Thermo Fisher Scientific, BioNxt Solutions, and AptarGroup - all key enablers for pharmaceutical and biotech companies. We present their business models and markets, highlighting where investors can spot particular opportunities – especially BioNxt, which occupies exciting niches with its innovations.
Read
Commented by Nico Popp on October 21st, 2025 | 07:00 CEST
Insights instead of data – this revolution is transforming entire industries: Aspermont, RELX, Verisk Analytics
Companies continue to evolve – luxury sports car manufacturer Lamborghini once built tractors. But what if, instead of building something entirely new, companies build on their experience and transfer a historically grown wealth of knowledge to the present? We present three exciting business models that demonstrate how modern AI innovations need a solid foundation to thrive. When that foundation exists, the opportunities for investors can be tremendous. Let's dive in with Aspermont, RELX, and Verisk Analytics.
Read
Commented by Nico Popp on October 17th, 2025 | 07:00 CEST
Crypto business models with yield potential: Nakiki, BlackRock, Marathon Digital
Bitcoin has long been an asset class in its own right. Despite recent price losses, more and more crypto enthusiasts remain convinced that Bitcoin will revolutionize the financial system. The reason: the currency cannot be inflated. Its maximum supply is already known. In October 2025, the Bitcoin price exceeded the USD 126,000 mark, reaching an all-time high. This rally has strengthened Bitcoin's reputation as a store of value and inflation hedge. At the same time, increasing amounts of institutional capital are flowing into regulated crypto investments. In the third quarter of 2025 alone, BlackRock's iShares Bitcoin Trust (IBIT) recorded inflows of USD 2.63 billion – the largest inflow into a Bitcoin ETF ever.
Read
Commented by Nico Popp on October 16th, 2025 | 07:10 CEST
Tungsten – Where the critical element is irreplaceable: Almonty, LAM Research, Rheinmetall
In recent days, the share price of tungsten producer Almonty Industries has known only one direction: upward. But why is there suddenly such hype surrounding a raw material that, only a few years ago, was known only to experts? The answer is clear: for decades, China lulled Western buyers into a false sense of security and drove foreign mine operators into bankruptcy through dumping prices. Today, Almonty remains the only major tungsten producer in the West, while numerous industries urgently depend on this critical element. We take a closer look at the demand structure of this unique high-tech and defense metal.
Read
Commented by Nico Popp on October 16th, 2025 | 07:00 CEST
Who definitely deserves credit in the fight against cancer: NetraMark, Moderna, BioNTech
Two biotech pioneers, Moderna and BioNTech, are back in the spotlight after their COVID-19 vaccine success - this time in a race to develop innovative cancer therapies. Both companies rely on mRNA technology to develop personalized cancer vaccines. Speed is crucial here: whoever brings effective treatments to market first could secure billions in market share. At the same time, AI startup NetraMark is entering the stage with novel data analysis that could significantly accelerate research and shape medical progress. We shed light on what is currently driving both the research community and investors.
Read
Commented by Nico Popp on October 15th, 2025 | 07:10 CEST
Hydrogen boom ahead: BMW, Toyota, Pure Hydrogen
Has the hydrogen hype cooled off? Not at all! Large companies are still investing heavily in this energy carrier. Industrial companies, such as those in the chemical sector, as well as automakers like BMW and Toyota, are all offering innovations related to hydrogen. But hydrogen is not just a topic for large corporations. Smaller mid-sized companies also need solutions for renewable energy for their factories or vehicle fleets. This is where the Australian company Pure Hydrogen comes into play – the hydrogen specialists' focus is on holistic solutions.
Read